Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019

Article Medicine, General & Internal

Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants

Laura L. Hammitt et al.

Summary: A single injection of nirsevimab administered before the RSV season protected healthy late-preterm and term infants from medically attended RSV-associated lower respiratory tract infection.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Letter Medicine, General & Internal

Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity

Joseph Domachowske et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018

Chelsea L. Hansen et al.

Summary: This study evaluated excess mortality from RSV and influenza in the US from 1999 to 2018, finding that RSV poses a greater risk to infants while influenza is associated with substantial mortality among elderly individuals.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Immunology

Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample

Mina Suh et al.

Summary: This study demonstrates that acute bronchiolitis due to RSV is the leading cause of hospitalizations in US infants, especially during the winter months.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Review Immunology

A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year( )

Mina Suh et al.

Summary: A systematic review of studies on respiratory syncytial virus (RSV) and bronchiolitis in US infants revealed substantial variability in the burden and healthcare utilization rates. Nationally representative studies are needed to understand the impact of RSV and healthcare utilization.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018

Heidi Reichert et al.

Summary: This study describes the mortality rate of infants in the United States due to respiratory syncytial virus (RSV). The highest mortality rates were observed among infants with a gestational age of less than 29 weeks, American Indian/Alaskan Native infants, and Medicaid-insured infants. However, the burden of RSV mortality was greatest in full-term infants, white infants, and Medicaid-insured infants.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Editorial Material Multidisciplinary Sciences